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Summary 
Cell migration requires coordination between integrin-mediated cell adhesion to the extracellular 
matrix and force applied to adhesion sites. Talin plays a key role in coupling integrin receptors to 
the actomyosin contractile machinery, while deleted in liver cancer 1 (DLC1) is a Rho GAP that 
binds talin and regulates Rho, and therefore actomyosin contractility. We show that the LD-motif of 
DLC1 forms a helix that binds to the 4-helix bundle of the talin R8 domain in a canonical triple-helix 
arrangement. We demonstrate that the same R8 surface interacts with the paxillin LD1 and LD2 
motifs. We identify key charged residues that stabilise the R8 interactions with LD-motifs and 
demonstrate their importance in vitro and in cells. Our results suggest a network of competitive 
interactions in adhesion complexes that involve LD-motifs, and identify mutations that can be used 
to analyse the biological roles of specific protein-protein interactions in cell migration. 
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Introduction 
Integrin-mediated cell adhesion to the extracellular matrix (ECM) involves the assembly of dynamic 
adhesion complexes and requires the spatial and temporal coordination of signalling and force 
transmitting events (Gardel et al., 2010; Wehrle-Haller, 2012). Such complexes form on the 
cytoplasmic tails of integrin receptors and mature into larger structures called focal adhesions (FA) 
in response to force exerted by the actomyosin contractile apparatus (Roca-Cusachs et al., 2012). 
The dimeric adaptor proteins talin1 and talin2 (molecular weight ~270 kDa) play a key role in the 
assembly of adhesion complexes (Zhang et al., 2008), and talin-null cells cannot adhere or spread 
on ECM, a phenotype corrected by expression of talin cDNAs (Atherton et al., 2015).  
Talin comprises an N-terminal FERM domain (~50 kDa) that binds to and activates integrins, 
connected to a large flexible rod (~200 kDa) that interacts with multiple ligands, including vinculin 
and F-actin (Calderwood et al., 2013). Integrin activation is implicated in cancer progression 
(reviewed in (Seguin et al., 2015)), and talin over-expression may therefore contribute to cancer 
metastasis (reviewed in (Desiniotis and Kyprianou, 2011)). The talin rod constitutes a force-
sensing module that regulates the assembly and maturation of adhesion complexes, and is 
composed of thirteen 4- and 5-helical bundles connected by short linkers, forming an extended 
flexible chain (Figure 1A) (Goult et al., 2013b). Several rod domains contain cryptic vinculin binding 
sites (VBSs) that become exposed as the talin domains unfold in response to force, enhancing 
vinculin binding (del Rio et al., 2009; Fillingham et al., 2005; Papagrigoriou et al., 2004; Yao et al., 
2014). Disruption of the talin force-sensing mechanism has strong effects on adhesion assembly, 
cell polarisation, and cell migration (Atherton et al., 2015). 
Talin also binds a number of proteins that regulate adhesion dynamics, including the Rap1-GTP 
interacting protein RIAM (Goult et al., 2013a; Lee et al., 2009), the Rac GEF Tiam1 (Wang et al., 
2012), and the Rho GAP DLC1 (Li et al., 2011). Recruitment of Tiam1 and DLC1 to adhesion 
complexes by talin is likely to have complementary effects, balancing Rac and Rho activity, thus 
creating a feedback mechanism between actin polymerisation, membrane protrusion, assembly of 
nascent adhesions, actomyosin driven FA maturation, and FA turnover (Devreotes and Horwitz, 
2015; Lawson and Burridge, 2014). The DLC1 binding site in talin has been mapped by deletion 
analysis to the 4-helix R8 domain (Li et al., 2011) that forms a unique protrusion in the C-terminal 
part of the rod that is otherwise comprised of a linear chain of 5-helix bundles (Figure 1A) (Gingras 
et al., 2010). Interestingly, R8 also contains binding sites for RIAM and vinculin, suggesting that the 
three ligands may compete for binding (Goult et al., 2013b). The talin binding site (TBS) in DLC1 
contains an LD-like motif that features in a wide range of other proteins, including the FA protein 
paxillin (Alam et al., 2014). The TBS in DLC1 interacts with the FA targeting (FAT) domain of FAK 
(Li et al., 2011), which also binds the LD-motifs in paxillin (Alam et al., 2014). The DLC1 
interactions with talin and FAK contribute to the biological activity of DLC1, including its tumour 
suppressor activity, establishing the physiological importance of these interactions (Li et al., 2011).  
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
P a g e  | 4 
 
Here we report the crystal structure of the talin R7R8 domains in complex with the TBS of DLC1; 
the DLC1 LD-motif forms a helix that binds to talin R8 in a consensus triple-helix arrangement 
between the contacting DLC1 and talin helices. We identify the main electrostatic interactions that 
stabilise the complex and use mutations to demonstrate the importance of the talin/DLC1 
interaction in cells. Based on the talin /DLC1 structure, we predicted that talin R8 might also bind 
paxillin LD-motifs; we demonstrate such an interaction by NMR and GST-pull downs, and show 
that the talin R8 rod domain plays a significant role in recruiting paxillin to FAs. We propose that 
LD-motif recognition sites in adhesion proteins such as talin and FAK are to a large degree 
interchangeable, creating a network of competing protein-protein interactions that regulate the 
properties of adhesion complexes. 
 
Results 
Structure of the DLC1/talin complex 
The talin-binding site (TBS) in DLC1 has been shown to require an 8-residue peptide 
469LDDILYHV476 located in the largely unstructured linker region (residues 78-639) between the 
SAM and GAP domains of DLC1 (Figure 1B) (Li et al., 2011). However, consensus secondary 
structure prediction using the NPSA server (https://npsa-prabi.ibcp.fr) indicates that the DLC1 
peptide is located at the N-terminus of a larger region with high helical propensity (residues 465-
488, Figure 1C), suggesting that the TBS in DLC1 may extend beyond residues 469-476. To 
explore this possibility, we used two synthetic DLC1 peptides (residues 461-489 and 467-489) that 
span the putative helical region. The shorter fragment starts with a proline residue, which usually 
disrupts helical structure, and is often located at the beginning or end of a helix.  
The minimal talin fragment required for interaction with DLC1 (Li et al., 2011) maps to the 4-helix 
bundle R8 domain in the talin rod (Figure 1A) (Gingras et al., 2010; Goult et al., 2013b). Addition of 
the DLC1(467-489) peptide induced large chemical shift changes in the HSQC spectra of 15N-
labelled talin R8 (Figure 1D) as did the larger peptide (data not shown), demonstrating the 
formation of a stable complex. Although the majority of resonances showed significant chemical 
shift changes, the overall pattern of cross-peaks was similar to that of free R8, suggesting the R8 
fold does not change upon DLC1 binding. 
The shorter DLC1(467-489) peptide was less soluble than the longer fragment, and was therefore 
less suitable for the NMR titration experiments. However, its lower solubility favoured crystallisation 
of a DLC1 peptide/talin complex. For these reasons, we used the longer DLC1 fragment for 
solution binding studies and the shorter fragment for crystallisation experiments. We crystallised a 
complex of DLC1(467-489) with the talin R7R8 fragment, the structure of which we previously 
determined in the free form (Gingras et al., 2010), and solved the structure of the complex by 
molecular replacement (Figure 2A; statistics in Table 1). As in the free form, the R7R8 talin rod 
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fragment adopts a unique fold where the R8 four-helix bundle is inserted into the loop connecting 
helices 3 and 4 of the R7 5-helix bundle. Individually, the structures of R7 and R8 in the DLC1 
complex are nearly identical to that of the free form (RMSD 0.35Å and 1.75Å, respectively), the 
main difference being the relative orientation of the two domains (Figure 2B).  
The linker region between R7 and R8 is well defined in the crystal structure and shows clear 
electron density at 1σ level. It forms a twisted, two-stranded antiparallel -sheet stabilised by 
hydrogen bonds. Each end of the linker has a pair of residues that make close contacts with the 
helical bundles (Figure 2B, C). Despite the different angle between the R7 and R8 domains in the 
complex and free forms, these contacts are maintained in both structures, suggesting that the 
freedom in domain orientation is mainly defined by the twist and bend of the -sheet linker. The 
linker may increase the stability of both domains by bringing together the ends of the helices 
connected to the linker. In support of the latter possibility, we found a strong effect of surface 
mutations (R1523E, K1530E and K1544E) on the solubility of the isolated R8 domain, likely 
caused by partial unfolding. The same mutations did not affect the fold of the R7R8 double domain 
(see later). 
As expected from sequence analysis and NMR data, the DLC1 peptide forms an -helix that 
interacts only with the talin R8 domain (Figure 2A and D). The peptide is well defined in the 
structure, with clear electron density at 1σ level (Figure S1A) and average B-factor values similar 
to those of the protein (Table 1). Only limited crystal packing contacts were observed between the 
external surface of the DLC1 helix and the edge of the R7 domain of the neighbouring molecule 
(Figure S1B). The minimal DLC1 binding region (469-476) identified by Li et al. (Li et al., 2011) 
corresponds only to the N-terminal half of the DLC1 helix, justifying the use of the extended 
fragment. The helix starts at E468, with the preceding Pro residue having an extended 
conformation. At the C-terminus, the helix ends at W486 with the adjacent SEK sequence (Figure 
1C), forming an extended structure.  
The DLC1/talin R8 complex resembles a talin 5-helix bundle 
The DLC1 helix docks into the hydrophobic groove formed by helices 2 and 3 of talin R8 
(Figures 2 and 3), forming a canonical left-handed antiparallel triple-helix coiled-coil arrangement 
(Figure S1C) (Lupas and Gruber, 2005). The topology and structure of the DLC1(467-489) 
complex with talin R8 have a striking resemblance to the 5-helix bundles of the talin rod (Figure 2D 
and E). The DLC1 helix is equivalent to the N-terminal helix (designated as 0) of the 5-helix 
bundle that is located at the distant interface between helices 2 and 3 of the 4-helix core of the 
structure in a cross-over arrangement (Goult et al., 2010; Goult et al., 2013b). 
As part of the 5-helix bundle, the 0 helix makes a set of hydrophobic contacts with the 4-helix 
core. These contacts are mediated by aliphatic side-chains located on the hydrophobic face of the 
amphipathic helix 0, which fits into the hydrophobic pockets at the interface between helices 2 
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and 3, following the general principle of “knobs into holes packing” found in helical bundles 
(Lupas and Gruber, 2005). The 0, 2 and 3 form a left-handed anti-parallel triple-helix coiled-coil 
that is similar to the triple-helix coiled coil formed by DLC1 with the 2-3 hairpin of R8 in the 
complex. The overall structure of the 5-helix bundles of the talin rod can thus be classified as 
conjoined 3/4 stranded coiled-coils (Moutevelis and Woolfson, 2009), adding a significant number 
of new members to this rare fold. 
DLC1 recognition by the talin R8 domain 
The contacts between DLC1 and R8 are mediated by the hydrophobic side-chains of L469, I472, 
V476, M479, V483, and W486 located on the hydrophobic face of the DLC1 helix (Figure 3D). 
These residues follow a typical heptad repeat of a coiled-coil (Lupas and Gruber, 2005), starting 
with L468 in position “a” (marked by letters at the top of Figure 3E); the contacting residues occupy 
positions “a” and “d” of the three sequential repeats. Additional hydrophobic contacts are made by 
the side chain of L473 in position “e” of the first repeat. At the N-terminal end of the DLC1 helix, 
corresponding to the LD-motif, residues L469, I472, L473, and V476 are embedded between the 
hydrophobic side chains of L1492 of the R8 2 helix, and  V1540, K1541, and I1543 of the 3 helix 
in a “knobs-into-holes” arrangement typical for the coiled coil packing, creating a small hydrophobic 
core (Figure 3B). The negatively charged DLC1 residue D470 that is conserved within LD-motifs 
(the “D” residue) makes direct contact with the positively charged side chain of K1544 in R8. The 
complementary hydrophobic surface of R8, together with the positively charged K1544, creates an 
LD-recognition box that matches the consensus features of LD-binding motifs (Hoellerer et al., 
2003) (Figure 3C). 
The middle of the 2-3 binding surface on talin R8 consists of small non-polar side chains that 
accommodate the hydrophobic residues V476, M479, and V483 in the middle of the DLC1 helix 
without creating any matching contacts (Figure 3B). This region generally shields the hydrophobic 
surface of the DLC1 helix from solvent, but is unlikely to make strong contributions to selectivity or 
affinity. The C-terminal hydrophobic residues V483 and W485 of DLC1 are packed against each 
other, and the side chains of K1510 and V1526 in R8, creating a small hydrophobic cluster that 
stabilises the end of the DLC1 helix (Figure 3B-D). 
The polar side chains of Q480 and N484 in DLC1 (positions “e” and “b” of the heptad repeat) make 
contacts with the matching polar groups of N1534 and N1538 at the edge of the R8 2-3 
hydrophobic patch, creating a polar ridge (Figure 3B). This ridge is extended by charge contacts 
between E488 of DLC1, which is wedged between the positively charged groups R1523 and 
K1530 of R8. These polar residues are not part of the LD-motif, but they generate DLC1-specific 
contacts that may contribute to recognition. The interaction between DLC1 E488 and R1523 and 
K1530 of talin R8 may explain why the DLC1 helix is disrupted at the C-terminus – in a continuous 
helix, E488 would be pointing away from the talin surface.  
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We tested the role of positively charged residues in talin by selectively reversing the charge of 
R1523, K1530, and K1544 (Figure 3B and 4A). Surprisingly, when these mutations were 
introduced into the isolated R8 domain, a large fraction of the protein was found in inclusion 
bodies, and the soluble fraction contained partially degraded protein. These observations suggest 
that although the mutations were at solvent-exposed positions, the R8 fold was destabilised. In 
contrast, the talin R7R8 fragment bearing the same mutations was soluble and stable. Similarity of 
the NMR spectra of the wild type and mutated R7R8 demonstrate that the protein fold was not 
affected.  
Single-residue mutations in talin R8 had variable effects on DLC1 binding to talin. The spectral 
changes for the R1523E talin R7R8 mutant were the closest to those of wild type, with large shifts 
and broadening of the signals indicating minimal effects on DLC1(461-489) binding (Figure S2A). 
Somewhat reduced shift changes and significantly less broadening was observed for the K1544E 
mutation (Figure 4C), and very limited shift changes with no additional broadening were observed 
for the K1530E mutant (Figure 4D). From these results, we conclude that K1530 makes the largest 
contribution to the interaction with DLC1. The contribution of K1544 is significant, but smaller, while 
the contribution of R1523 is negligible. However, none of the single mutations completely 
abolished the interaction with DLC1. To enhance the effects of the mutations, we generated the 
K1530E/K1544E double mutant; this 2E R7R8 double mutant showed negligible chemical shift 
changes on addition of DLC1 (Figure 4E), effectively disrupting the interaction between talin R8 
and DLC1.  
To validate the ion pairing between D470 and E488 of DLC1, and K1530 and K1544 of talin R7R8, 
we introduced charge-reversal mutations D470K/E488K in DLC1, complimentary to 
K1530E/K1544E of talin. The addition of the double D470K/E488K DLC1 mutant to the 
K1530E/K1544E talin R7R8 induced significant chemical shift changes (Figure 4F). These 
changes were not as large as those observed with the wild type proteins, but were comparable to 
the changes observed with the K1530E mutant. The D470K/E488K DLC1 mutant also showed 
some interaction with the wild-type R7R8, although not as strong as the wild type DLC1 (Figure 
S2B). The incomplete recovery of the interaction and residual binding of the mutated DLC1 may 
reflect the ability of the peptide to adopt a slightly different conformation in the complex due to its 
small size and flexibility. Although further optimisation will be required to enhance the interaction 
between the DLC1/talin R8 charge reversal mutants, the results support the roles of the charged 
residues in DLC1 recognition by talin. 
Comparison of DLC1, RIAM and paxillin complexes  
The talin-binding LD-motif of DLC1 interacts with the LD-binding FAT domain of FAK and was 
initially identified through its homology with paxillin LD-motifs (Li et al., 2011). From the sequence 
homology and structural similarity, we predicted that paxillin LD-motifs should also interact with the 
talin R8 domain. Indeed, we observed large chemical shift changes in the 1H,15N-HSQC spectra of 
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talin R8 and R7R8 on addition of paxillin LD1 (Figure 5A, S2C) and LD2 peptides (data not shown). 
The amplitudes of the chemical shift changes were comparable to those induced by DLC1 
(compare with Figure 1D), although a smaller number of resonances were affected. The chemical 
shift changes map predominantly to the LD-motif binding region of the talin R8 domain (Figure 5B). 
No chemical shift changes were detected on the interfaces formed by other R8 helices, 
demonstrating that R8 has only a single LD-motif binding site unlike the FAT domain of FAK, which 
has two (Figure 5B) (Hayashi et al., 2002; Hoellerer et al., 2003). 
 Overall, the topology of the R8/DLC1 and FAK/paxillin complexes is similar, and binding is 
mediated by similar residues (Figure 3E and 5B), suggesting that the paxillin LD-motif interacts 
with the LD-recognition box in talin R8. In this orientation only a single ion pair between K1544 of 
talin R8 and the D-residue of the paxillin LD-motif is expected to form, potentially making the 
contribution from this contact more prominent. Consistent with this prediction, we detected only 
minor chemical shift changes in the K1544E talin R7R8 mutant on addition of paxillin LD1 (Figure 
5C). 
Using an LD-motif deletion mutant of DLC1, we previously demonstrated that the DLC1/talin 
interaction contributes to DLC1 adhesion targeting (Li et al., 2011). To assess whether the 
interaction with talin R8 has similar effect on paxillin localisation, we compared talin:paxillin and 
talin:DLC1 ratios in talin1 and talin2 knockout (TKO) cells (Atherton et al., 2015) transfected either 
with wild-type talin or a talin mutant lacking the R8 domain (talR8). The relative abundance of 
both DLC1 and paxillin in adhesions was significantly and comparably reduced in cells expressing 
talR8 (Figure 5D). Reduced DLC1 localisation was analogous to what we had seen earlier with 
the DLC1 mutant (Li et al., 2011), providing independent evidence that talin R8 is the interaction 
site for DLC1, thus validating our approach. The reduced localisation of paxillin in FA provides the 
first evidence that talin directly contributes to paxillin recruitment to FA. 
Besides DLC1 and paxillin, the R8 domain also binds RIAM (Goult et al., 2013b). The recently 
reported structure of the R8/RIAM complex (Chang et al., 2014) shows that, similar to DLC1, RIAM 
forms a helix that fits into the hydrophobic groove the 2 and 3 helices of talin R8 (Figure 3F; 
(Chang et al., 2014)). Although not identified as an LD-motif, the sequence of RIAM has a 
characteristic distribution of negatively charged and hydrophobic residues (Figure 3E) that explains 
the interaction with the LD-recognition surface of R8. In support for the similarity of DLC1 and 
RIAM recognition by R8, we observed a strong reduction in RIAM binding affinity for the 
R1530E/K1544E mutant (Figure S2E, F). 
Interestingly, in the R8/RIAM complex (Chang et al., 2014), the RIAM helix has an unusual kink, 
which causes its displacement relative to DLC1 (Figure 3F). However, the critical hydrophobic 
side-chains that make contacts with the surface of talin R8 are located in similar positions, and 
make contacts with similar residues on R8, particularly at the N- and C-terminal ends of the helices 
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(Figure 3G). These residues occupy equivalent positions in the sequences of the two proteins, 
showing that the DLC1 and RIAM helices are generally in register relative to each other (Figure 
3E). 
The kink in the RIAM helix appears to be forced by the hydrophobic contacts of the aromatic ring of 
F12, which is inserted between helices 2 and 3 of talin R8. In DLC1, the equivalent L473 
occupies a peripheral position and is partly exposed to solvent. The helical kink is energetically 
unfavourable, but may be partially compensated by the hydrogen bond involving RIAM S13, as 
suggested by Chang et al. (Chang et al., 2014). Significantly, no kink is present in the RIAM helix 
in complex with vinculin determined by X-ray crystallography (Goult et al., 2013b), nor with the talin 
F3 domain determined by NMR (Yang et al., 2014). These arguments support an induced kink 
model, rather than a stable kinked helix model proposed by Chang et al. (Chang et al., 2014). 
Additional contributions to the kink in the RIAM helix may be due to crystal packing (Figure S1D). 
Changes in the NMR spectra of R8 on ligand addition suggest different affinities for the interactions 
between talin and DLC1, RIAM and paxillin. The strongest effects on the spectra were observed for 
RIAM, where many signals shifted and broadened significantly at R8:peptide ratio as low as 1:0.1. 
For DLC1, similar broadening and shifts were observed, but required a higher ratio of 1:0.5, while 
for paxillin only chemical shift changes were detected. For each peptide, the chemical shift 
changes of the signals that showed only limited broadening throughout the titration (corresponding 
to a fast exchange regime) could be successfully fitted to the theoretical binding curves, with 
similar dissociation constants (Figure S3). In agreement with the qualitative analysis, the Kd values 
determined by fitting were 48, 3.5 and 168 µM for DLC1, RIAM and paxillin, respectively. Overall, 
the measured Kd values are within the range of the low to high µM values reported for biologically 
relevant LD-motif interactions (Alam et al., 2014), and the value for RIAM is in excellent agreement 
with that reported earlier (Chang et al., 2014). The high affinity of talin R8 for RIAM likely reflects 
the larger contribution of hydrophobic side-chains to binding, while the lower affinity for paxillin 
correlates with the smaller binding region.  
Biological implications for DLC1-talin interaction from mutational analysis 
We reported previously that wild type talin R8 is sufficient to form a complex with full length DLC1 
in cells (Li et al., 2011). To evaluate the effects of the single K1530E and K1544E and double 
K1530E/K1544E (2E) R8 mutants on the complex formation in vivo, GST-tagged R8 constructs 
were engineered into isogenic mammalian expression plasmids, and co-transfected with GFP-
DLC1 into HEK 293T cells. Complex formation was determined by a GST pull-down assay. 
Consistent with the NMR results, the talin R8 K1530E mutation caused a greater reduction in 
DLC1 binding than K1544E, while the 2E double mutant reduced binding to a greater extent than 
either single mutant (Figure S2D).  
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We next compared the ability of the wild type talin R8 and mutant constructs to compete with 
binding of endogenous talin to GFP-DLC1 in cells, to see whether the GFP-DLC1-dependent 
biological effects require the interaction with talin R8. For this experiment we used three pairs of 
GST-tagged talin constructs that each contained R8; (i) the wild type talin R8 and 2E constructs 
described above (encoding amino acids 1453-1580),(ii) talin R7R8 and equivalent 2E constructs 
(encoding amino acids 1352-1580), and (iii) wild type and 2E talin constructs spanning residues 
1288-1646 that was used previously (Li et al., 2011).  GST served as negative control in the assay. 
We first confirmed that complex formation with GFP-DLC1 as determined by GST pull-downs, was 
greater for each wild type talin fragment than for the respective 2E mutant (Figure 6A). The wild 
type versions of each talin construct should therefore compete with endogenous talin for binding to 
GFP-DLC1 more effectively than the 2E mutant. To evaluate this, talin was immune precipitated 
from the supernatants of the GST pull-downs and blotted for GFP-DLC1; co-expression of GST 
with DLC1 or with vector served, respectively, as a positive and negative control (Figure 6B). 
Substantially less GFP-DLC1 co-immunoprecipitated with talin in cells co-transfected with 
constructs containing wild type R8 versus the 2E mutants (Figure 6B). We conclude that each wild 
type GST-talin polypeptide inhibits binding of GFP-DLC1 to endogenous talin more effectively than 
the respective 2E mutant.  
To assess the biological effects of inhibiting the interaction between endogenous talin and GFP-
DLC1, the ability of each talin wild type and 2E mutant pair to antagonize the activity of co-
transfected GFP-DLC1 was tested in the A549 human non-small cell lung cancer line. Equivalent 
expression levels of each talin construct were confirmed by western blotting (Figure 6C). We used 
three different bio-assays (details in Supplementary): monolayer colony growth (Figure 6D), growth 
in soft agar (Figure 6E), and transwell cell migration (Figure 6F). In the absence of any co-
transfected talin fragment, GFP-DLC1 was inhibitory in all three assays, while the GST-R8 talin 
construct (wt or 2E mutant) by itself had no detectable biological activity, as its effects were similar 
to that of the GST negative control (Figure S4).  However, each wild type talin polypeptide 
attenuated the inhibitory activity of GFP-DLC1 in all three bio-assays, consistent with its efficient 
displacement of endogenous talin from GFP-DLC1. By contrast, each 2E mutant had only a 
marginal effect on the inhibitory activities of GFP-DLC1. The results clearly demonstrate that the 
biological activity of DLC1 is associated with its interaction with talin and confirm the importance of 
the talin R8 residues K1530 and K1544 to the interaction. 
However, as talin R8 interacts with RIAM (Goult et al., 2013b) and paxillin (shown here) in addition 
to DLC1, we used several approaches to evaluate whether binding of talin R8 to endogenous 
RIAM or paxillin might have contributed to the observed results. For RIAM, the level of expression 
in the cell lines used here varied from very low to undetectable. To detect RIAM protein in any of 
the cell extracts, we had to use an anti-RIAM immunoprecipition step followed by anti-RIAM 
immunoblotting. Using these conditions, endogenous RIAM was detected in A549 and H358 cells, 
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but not in 293T cells (Figure S5A). In A549 cell extracts, which contain endogenous RIAM, anti-
RIAM immunoblotting did not detect a GST-R8 complex (Figure S5B left), whereas the wild-type 
GST-R8, but not the 2E mutant, did bind GFP-DLC1 under the same conditions (Figure S5B right). 
The failure to detect a R8/RIAM complex despite the higher affinity of R8 for RIAM versus DLC1 
suggests that the biological effects induced by GST-R8 are unlikely to mediated via RIAM.  
To investigate whether the biological effects of GST-R8 might be partly mediated via paxillin, we 
first confirmed that endogenous paxillin is expressed in cell lines A549, H358, and 293T (Figure 
S6A). However, the levels of endogenous paxillin in A549 and H358 cells, in combination with its 
relatively low affinity for DLC1, were insufficient to detect binding to GST-R8, using the pull-down 
assay (Figure S6B top and bottom, respectively). As a positive control, HEK293 cells were co-
transfected with a paxillin-DDK construct (OriGene) and GST-R8 (wild-type, R1544E and 2E 
mutants), followed by a GST pull-down assay. Under these conditions, wild-type GST-R8 did bind 
paxillin-DDK, and it did so more efficiently than 2E GST-R8 talin mutant (Figure 6SC).  
Taking together, we conclude that the ability of wild type GST-talin R8 to inhibit growth and 
migration in A549 cells is largely attributable to its interaction with DLC1, as no effect was 
observed in the absence of DLC1, and binding to endogenous RIAM and paxillin in cell extracts 
was undetectable under conditions associated with a strong DLC1 interaction.  
 
Discussion  
The interaction between talin and DLC1 plays a key role in recruiting DLC1 to FAs and contributes 
to the tumour suppressor activity of DLC1 (Li et al., 2011). Although deletion analysis has been 
successfully used to identify regions that are critical for talin interaction with DLC1 (Li et al., 2011), 
the exact location of the binding sites and the mechanism of the interaction remained unknown. 
Here, we refine the boundaries of the talin binding site (TBS) in DLC1 and report the crystal 
structure of this region in complex with the talin R7R8 rod domains. Analysis of the structure 
identifies the general features of the DLC1 binding site in the talin R8 4-helix bundle and the 
specific residues involved. Thus, a talin R8 K1530E/K1544E double mutant markedly reduced 
binding to DLC1 peptides in vitro, and to full length DLC1 in cells, compromising the ability of GST-
talin R8 constructs to displace DLC1 from endogenous talin and thereby to attenuate the tumour 
suppressor activity of DLC1. Sequence similarity between the TBS in DLC1 and paxillin LD-motifs 
suggested a possible interaction between talin and paxillin, and we have confirmed this novel 
interaction by NMR, and shown that it is an important factor in determining paxillin levels in FAs. 
Taken together, our results explain how talin R8 recognises LD-motifs in both DLC1 and paxillin, 
and suggest that talin forms part of an LD-motif-based network of interacting proteins that 
contribute to the assembly and regulation of adhesion complexes. 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
P a g e  | 12 
 
Our structure of the talin R7R8/DLC1 complex demonstrates that the TBS in DLC1 forms a helix 
that packs against the two adjacent 2 and 3 helices of the talin R8 4-helix bundle in a consensus 
left-handed triple-helix coiled-coil arrangement. The DLC1 binding site in talin is fully accessible to 
solvent, and the conformation of the R8 domain does not change on binding. The resulting 5-helix 
coiled-coil complex can be classified as a hybrid conjoined 3/4-stranded coiled-coil (Moutevelis and 
Woolfson, 2009). A similar structure is formed in the talin R8/RIAM (Chang et al., 2014) and 
paxillin/FAK (Hoellerer et al., 2003) complexes. Although classified as a rare fold (Moutevelis and 
Woolfson, 2009), the 3/4-stranded coiled-coil is likely to be a relatively common topology for 
complexes between 4-helix bundles and isolated helices as it minimises the rearrangement of the 
4-helix core. 
Recognition that the interaction between DLC1 and talin R8 involves coiled-coil packing allowed us 
to analyse the interaction, using well-established rules for coiled-coil structures. The TBS in DLC1 
contains a typical heptad repeat identified in left-handed coiled-coils (Lupas and Gruber, 2005) 
(Figure 3) that creates a hydrophobic interaction surface. Flanking this region are polar residues 
that contact complementary polar residues in talin R8. We identified three regions on the talin R8 
surface that aid recognition of the DLC1 helix: (i) an LD-recognition box consisting of a 
hydrophobic cluster with an embedded positive charged amino acid that matches the consensus 
LD-motif, (ii) a polar ridge that generates a network of polar contacts and hydrogen bonds between 
DLC1 and R8, and (iii) a small hydrophobic patch that contacts the C-terminal hydrophobic 
residues of the DLC1 helix. Additionally, the R8 binding surface lacks any charged or large polar 
residues along the whole interface between the 2 and 3 helices, thus avoiding any unfavourable 
contacts with the hydrophobic residues in the middle of the DLC1 helix. Together, these features 
create a complementary surface that can accommodate the entire length of the DLC1 TBS helix 
(Figure 3). 
Among the contacts identified between DLC1 and talin R8, charge complementarity within the 
polar ridge (Figure 3) is likely to define ligand selectivity. We confirmed this prediction by reversing 
the charges of K1530 and K1544 at opposite ends of the binding region in R8. While double 
charge reversal completely abolished DLC1 binding, single charge reversals had only a partial 
effect, demonstrating that both interactions contribute to ligand recognition. Paxillin LD-motifs form 
significantly shorter helices that correspond to the N-terminal half of the DLC1 helix, and interact 
only with the LD-recognition box. In this case charge reversal of K1544 in the LD-recognition box of 
R8 (Figure 3C) had much stronger effect on the interaction with paxillin, practically abolishing 
binding. This observation highlights charge complementarity as a general feature of LD-motif 
recognition, with additional contributions outside the LD-box fine-tuning the interactions with 
specific ligands. 
 Our results further support the important contributions of weak interactions to the adhesion 
mechanisms. Despite the relatively low affinities of DLC1 and paxillin for talin R8 (Kd’s of 48 and 
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168 µM, respectively), these interactions can be detected in cells, and their disruption strongly 
reduces the abundance of DLC1 and paxillin in FAs (Figure 5D). For DLC1 this affects adhesion-
dependent colony growth and migration, although the biological role of the talin-paxillin interaction 
is currently unclear and will need further investigation. Large differences in the dissociation 
constants of DLC1, RIAM and paxillin interactions with talin R8 are in line with the low to high µM 
range of constants determined for other LD-motif interactions (Alam et al., 2014). These 
interactions are likely to be enhanced through the high concentration of the binding sites within 
adhesion complexes. 
Although not previously identified as an LD-motif, the N-terminal part of the TBS in RIAM shows a 
similar pattern to DLC1, with hydrophobic and charged residues that fit the LD-recognition box in 
talin R8 (Figure 3). DLC1 also binds to the FAK FAT domain, a recognised partner for paxillin LD 
motifs, and R8 itself interacts with paxillin. Extending this set of interactions, other LD-motif binding 
proteins, such as PYK2, that have 4-helix bundle structures (Alam et al., 2014) may also interact 
with DLC1 and RIAM. In turn, LD-motifs of other proteins, including members of the paxillin family, 
such as leupaxin and Hic-5, may interact with talin. The combination of an LD-like helix and a 4-
helix bundle containing an LD-recognition box may be a common feature amongst interacting 
adhesion proteins serving alongside other interacting pairs such as SH3 domain/polyproline 
sequences. The critical contribution of charged residues to recognition of the LD-motif and 
additional interactions outside the LD-motif can be used to selectively modulate the binding of 
specific ligands, as we demonstrated for DLC1, paxillin and RIAM using charge-reversal mutations. 
Comprehensive analysis of talin has revealed multiple ligand binding sites in the 13 talin rod 
domains, often arranged in complex overlapping patterns (Goult et al., 2013b). There are 11 VBSs 
in the talin rod, and the talin/vinculin interaction plays a key role in stabilising FAs (Carisey et al., 
2013). There are 5 putative RIAM binding sites in talin (4 in the rod) that have the potential to 
regulate the initiation of adhesion complex assembly (Goult et al., 2013b; Yang et al., 2014). 
Additionally, we now identify a paxillin binding site in the talin rod, and more talin interactions may 
be discovered.  In turn, RIAM itself has two talin binding sites that can also bind vinculin (Goult et 
al., 2013b), and paxillin has 5 LD-motifs, several of which interact with vinculin and FAK (Hoellerer 
et al., 2003). A direct link between talin and FAK has also been reported (Lawson et al., 2012; 
Lawson and Schlaepfer, 2012), although molecular details of this interaction are missing. DLC1 
has at least one binding site that interacts with talin and FAK in a similar way. All these interactions 
create a complex network at the core of adhesion complexes, where mechanosensing molecules 
such as talin and vinculin link to each other and to signalling molecules like FAK and DLC1, either 
directly or indirectly through adaptor proteins such as RIAM and paxillin. 
Strikingly, all talin rod 5-helix bundles, except the C-terminal R13 actin-binding domain (Gingras et 
al., 2008; Goult et al., 2013b), have the same 3/4-stranded coiled-coil topologies. The significance 
of this is currently not understood, although some speculation can be made based on comparison 
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with the DLC1/talin R8 complex, which has the same helix arrangement as a talin rod 5-helix 
bundles (Figure 2). The core of the fold is a typical 4-helix bundle that is likely to remain stable 
when the N-terminal 0 helix is removed - the talin R8 4-helix bundle is perfectly stable in the 
absence of DLC1, and removal of the N-terminal 0 helix from the R10 domain generates a stable 
4-helix bundle (Gingras et al., 2006; Goult et al., 2010) that is similar to R8. This suggests that 
under some conditions, talin 5-helix domains may exist as 4-helix bundles, raising the exciting 
possibility that removal of the 0 helix might expose cryptic binding sites that can interact with 
helical regions homologous to the 0 sequence. The VBSs in the talin rod are buried in the 
hydrophobic core of the helical bundles in which they are contained (Calderwood et al., 2013), and 
force exerted on talin is required to expose these sites (del Rio et al., 2009; Yao et al., 2014). It is 
therefore tempting to speculate that force may also play a role in displacing the 0 helix in talin rod 
5-helix bundles, exposing cryptic binding sites for proteins such as those containing LD-motifs. 
Although talin is widely recognised as a key player in adhesion complex assembly, the extent of 
the talin interaction network is unclear, and no comprehensive proteomic study on talin-binding 
partners has been reported. Rather, the majority of studies have concentrated on individual 
interactions that are often prominent under specific conditions. Experiments in live cells 
demonstrate that adhesion complex assembly has a high tolerance for deletion of individual 
proteins, as well as deletions or mutations of individual binding sites. This implies a high level of 
redundancy in the system, some of which may be due to the multi-site interactions between FA 
proteins.  
EXPERIMENTAL PROCEDURES 
Peptides and protein preparation – Recombinant wild-type mouse talin1 fragment R7R8 
(residues 1357-1653) was previously cloned into pET151/D-TOPO expression vector (Gingras et 
al., 2010). Site directed R7R8 mutants were produced by overlap extension PCR, and subsequent 
ligation-independent cloning into pOPINB vector (OPPF-UK). Protein was produced in BL21 STAR 
(DE3) cultured in LB or 2xM9 minimal medium containing 1 g/L of 15N-labelled NH4Cl, and purified 
using nickel-affinity chromatography followed by ion exchange.  
X-ray crystallography – Sitting-drop sparse matrix crystallisation screens were set up using 300 
μM solution of talin R7R8 fragment in the presence of 8-fold molar excess of DLC1(467-489) 
peptide. Crystals were obtained in 15% Ethanol, 0.1 M Tris pH 7.4 at 4oC and vitrified in sodium 
malonate pH 7 prior to data collection. The DLC1-R7R8 complex was solved using molecular 
replacement using the structure of the free R7 domain as a template (2X0C) (Gingras et al., 2010). 
Initial electron density maps showed that the position of the R8 domain had changed, and once 
repositioned, and the R7R8 domain modelled, electron density for the DLC1 peptide was clearly 
visible, as demonstrated in the simulated annealing composite omit map (Supplementary Figure 
S1A). Refinement was performed using isotropic B-factors, and at the final stage of refinement 
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employed the use of TLS parameters. Data reduction and refinement statistics are shown in Table 
1.  
NMR spectroscopy - NMR spectra were collected on Bruker Avance III 600 and 800 MHz 
spectrometers equipped with CryoProbes. Experiments were performed at 298 K in 20 mM sodium 
phosphate pH 6.5, 50 mM NaCl with 5% (v/v) 2H2O. Dissociation constants were evaluated from 
the 1H,15N-HSQC chemical shift changes in the titration experiments conducted using 0.1 mM 15N-
talin R8 domain. Peptides were added from 5-10 mM stock solutions to generate titration points at 
0.1, 0.2, 0.5, 0.75, 1, 2, 4 and 8 peptide:protein ratios. 
Cell-based assays - The plasmids expressing GFP-DLC1 and GST fusion proteins with talin rod 
fragments encoding talin amino acids 1288-1646 and 1453-1580 (R8) were described previously 
(Li et al., 2011). The plasmid encoding 1352-1580 (R7R8) was engineered by PCR, and subcloned 
into a eukaryotic expression vector, PEBG. HEK 293T cells were transfected by lipofectamine 
2000 and DLC1-null lung adenocarcinoma cell lines A549 and H358 cells were transfected by 
lipofectamine 3000 according to manufacturer instructions (Invitrogen). Cells were co-transfected 
with plasmids expressing GFP-DLC1 or Paxillin-DDK and GST, GST-talin fragments, or vector at a 
ratio of 1:2.5.  Cells were incubated at 37 oC in a humidified 5% CO2 atmosphere. In vivo pull-down 
assay, co-immunoprecipitation, immunoblotting, G418 colony growth, soft agar growth and cell 
migration assays were described previously (Qian et al., 2009). 
Ratio imaging - Talin1 and talin2 knock out cells were generated and cultured as described in 
(Atherton et al., 2015). Transient transfections were performed using Lipofectamine and Plus 
reagents (Life Technologies) as per the manufacturer’s instructions. Cells transfected with GFP-
talin proteins were incubated overnight on glass bottom dishes (MatTek), fixed with 
4% paraformaldehyde and permeabilised with 0.5% Triton X-100 (Sigma). Samples were 
incubated with the primary antibody for 60 min, and then washed thrice with PBS. Secondary 
antibody staining followed the same procedure. Fixed samples were imaged using a Delta Vision 
RT microscope (Applied Precision) equipped with a 60 × /1.42 Plan Apo oil immersion objective 
(Zeiss). Images were acquired with a CoolSnap HQ camera (Photometrics). images were 
background subtracted, a region of interest was selected around an individual peripheral adhesion 
(5 per cell) and the integrated density measured for both channels. Dividing the values from paxillin 
or DLC1 by talin then produced a ratio. 
Further details can be found in the Supplementary. 
Accession codes.  
The coordinates for the structure of the talin R8/DLC1 complex have been deposited to PDB, 
accession code 5FZT. Backbone chemical shifts of the talin R8 have been deposited to BRMB 
accession code 19339. 
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Figure legends 
Figure 1. DLC1(467-489) interacts with the talin R8 domain. (A) Model of the talin rod based on 
the structures of individual domains. Domain R8 interacts with DLC1. (B) Domain composition of 
DLC1. The location of the talin binding site (TBS) in the largely unstructured serine-rich linker 
region is indicated. (C) Secondary structure prediction for the TBS in DLC1 which includes an LD-
motif marked by the red box. “h” – regions of high helical propensity; “c” – random coil regions. 
Fragments used in this study are indicated by the thick blue lines. (D) Superposition of the 1H,15N-
HSQC spectra (298K, 800MHz) of 100 μM talin R8 domain in the free form (blue) and in the 
presence of 4-fold excess of DLC1 (467-489) (red). See also Figure S3. 
Figure 2. Structure of the talin-DLC1 complex. (A) Cartoon representation of the X-ray structure 
of the talin R7R8 fragment (green) in complex with DLC1(467-489) (orange). (B) Superposition of 
the crystal structure of R7R8 in the free form (cyan) and in complex with DLC1(467-489) (green) 
aligned on the R7 domain. Residues at the ends of the linker regions between R7 and R8 are 
shown in stick representation (red) and labelled. (C) Two-stranded antiparallel twisted -sheet 
formed in the linker region. Side-chains of the residues highlighted in (B) are shown in the stick 
representation and labelled. (D) Comparison of the structure of the talin R8/DLC1(467-489) 
complex (left) and the talin R10 domain (PDB ID 2KVP; right). The DLC1 helix and 0 helix of talin 
R10 are highlighted in orange. (E) Topology of the talin R8/DLC1(467-489) complex (left) and talin 
R10 (right). See also Figure S1. 
Figure 3. Recognition of the DLC1(467-489) helix by the talin R8 domain. (A) Position of the 
DLC1(467-489) helix (orange) relative to the 2 and 3 helices of talin R8 (green). (B) DLC1 and 
talin residues that make contacts in the complex. Side-chains of the residues involved in 
hydrophobic interactions are shown as balls; charged and hydrophilic interactions are shown as 
balls-and-sticks. Blue rectangle identifies the “polar ridge” of the complex. (C) DLC1-interacting 
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residues on the talin surface. LD-recognition box is marked by red rectangle. (D) Talin-interacting 
residues on the surface of DLC1 helix. The helix is rotated by 180o around the vertical axis relative 
to the orientation in (B). (E) Sequence alignment of DLC1 with RIAM TBS and paxillin LD domains. 
Peptide fragments used to solve the structures of the complexes are underlined. Residues involved 
in the interactions with the corresponding proteins are highlighted in magenta (hydrophobic 
interactions) and orange (charge and hydrophilic interactions). For paxillin LD1 the underlined 
region corresponds to the LD-motif. Positions of the coiled-coil heptad repeat are shown above the 
sequences. The underlined positions “a” and “d” correspond to the interacting hydrophobic 
residues in coiled-coils. (F) Comparison of the positions of DLC1 and RIAM helices in the 
complexes with the talin R8 domain. (G) Locations of the hydrophobic residues on the surfaces of 
the DLC1 and RIAM helices involved in the interaction with talin R8. The helices are rotated by 
180o around the horizontal axis relative to the orientation in (F). See also Figure S1. 
Figure 4. Interactions of charge-reversal mutations of talin R7R8 and DLC1(461-489). (A) 
Location of the mutated residues in the structure of talin R8/DLC1(467-489) complex. (B-F) 
Superposition of the HSQC spectra of 0.2 mM talin R7R8 free (blue) and in the presence of 0.8 
mM DLC1(461-489) (red). Mutations are marked on the spectra; wt – wild type form of the protein. 
See also Figure S2. 
Figure 5. Interaction of paxillin LD-motifs with talin R8. (A) Superposition of the HSQC spectra 
of 0.1 mM talin R8 free (red) and in the presence of 0.4 mM paxillin LD1 (blue). (B) Comparison of 
structures of talin R8/DLC1 and FAK/paxillin complexes. From left to right: side view of the 
R8/DLC1 complex – the DLC1 helix is in orange with the LD-motif highlighted in red; front view of 
the R8/DLC1 complex, largest chemical shift perturbations caused by LD1 binding are highlighted 
in purple; structure of the FAK complex with LD2 bound to the 2-3 site (helices α2 and α3) and LD4 
bound to the 1-4 site (helices α1 and α4) (PDB ID 1OW7). (C) Superposition of the HSQC spectra 
of 0.2 mM talin R7R8 K1544E mutant free (red) and in the presence of 0.8 mM paxillin LD1 (blue). 
(D) Ratio imaging was used to determine the proportion of endogenous paxillin and DLC1 present 
at FA in TKOs expressing either talin FL or talin ΔR8. Quantitative analysis shows that both paxillin 
and DLC1 are markedly reduced in adhesions when talin R8 is deleted (n=20 cells from three 
independent experiments, **=P<0.01m ***=P<0.001 (ANOVA)). White line indicates cell margin. 
See also Figure S2 and S3. 
Figure 6.  Talin R8 mutations disrupt the interaction with DLC1 and affect its biological 
activity. (A) Wild type GST-talin fragments pull-down more DLC1 than the 2E mutants. Extracts of 
HEK 293T cells transfected with GFP-DLC1 and GST-talin constructs were subjected to pull-down 
assays with glutathione beads followed by immunoblotting with anti-GST and anti-DLC1 on the 
same membrane (top). The transfected GFP-DLC1 in each sample is shown by the anti-DLC1 blot 
(bottom) as a loading control. (B) Wild type GST-talin fragments compete efficiently with 
endogenous talin to form a complex with DLC1. The supernatants collected after pull-down assay 
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from (A) were reused for co-immunoprecipitation with an anti-talin antibody and blotted with anti-
DLC1 (top). A small aliquot from each lane was blotted for endogenous talin as a loading control 
(bottom).  (C) Co-expression of GST or GST-talin fragments (wild type or 2E mutant) with GFP 
DLC1 in A549 cells. Six days after transfection, A549 cell lysates were blotted with anti-DLC1 (top) 
and anti-GST (bottom) to conform equal protein expression. (D) G418 colony growth assay. 
Transfected A549 cells were cultured in G418 for 3 weeks, and colonies counted and quantitated 
(top). Representative stained colonies are shown (bottom). (E) Growth in soft agar.  Transfected 
A549 cells were grown for 3 weeks in soft agar, and colonies counted and quantitated (top). 
Representative stained whole dishes are shown (bottom). (F) Transwell cell migration assay. 
Lysates from migrated cells were quantitated (top), and representative microscopic images of the 
migrated cells are shown (bottom). See also Figure S4-6. 
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Figure 6
Table 1 – Data Collection and refinement statistics of the R7R8/DLC1  
                complex. 
  
Data Collection 
    Beamline I03 
    Wavelength (Å) 0.97 
    Resolution Range (Å) 55.18-2.1(2.2-2.1) 
     Space Group P3121 
     Unit Cell 
 
a, b, c (Å) 73.26 73.26 111.82 
α, β, γ (°) 90 90 120 
    Unique reflections 20847 
    Multiplicity 7.8 (7.6) 
    Completeness (%) 100 
    Mean I/σ 10.11 (2.8) 
    Wilson B-Factor (Å2) 31.16 
    R-Merge (%) 12.8 (65.8) 
    CC1/2 0.998 (0.79) 
Refinement 
   Unique reflections 19777   
   R-Work (%)    17.66 (20.3) 
   R-free   (%)    23.06 (26.4) 
   Number of Atoms 2635 
               Macromolecule 2456 
  Protein residues 329 
  RMS-bonds (Å) 0.008 
  RMS-angles (o) 0.9 
Ramachamdran Favoured  
(%) 
98.2 
Ramachamdran Allowed    
(%) 
1.8 
   Average B-factors (Å2) 
 
         R7R8 main chain 34.393 
         R7R8 side chain           42.621 
         DLC1 main chain 28.756 
 
 
         DLC1 side chain 38.327 
         Solvent           39.68 
 
 
 
Rfree is calculated using 5% of data isolated from refinement. Data from highest 
resolution shell in brackets. 
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 Figure S1, related to Figures 2 and 3. Structural characteristics of R7R8/DLC1 complex 
(A) Structure of DLC1 peptide is well defined in the complex. Simulated annealing composite 
omit map 2F0-FC shown at 1σ (blue, left) and the refined 2F0-FC map (blue, right) of the DLC1 
LD-motif shown at 1σ superimposed on the structure of the DLC1 peptide in the complex (orange) 
show a good match between the structure and the electron density. 
(B) Crystal packing contacts in the R7R8/DLC1 complex. Outer surface of the DCL1 helix (red) 
makes limited contacts with the edge of the R7 domain of the symmetry-related molecule. 
(C) Triple-helix structure in the talin R8/DLC1 complex. Similarity between the arrangement of 
the 2-3 hairpin of the talin R8 and DLC1 fragment from the R8/DLC1 complex (left) and the 
single-chain, triple-helix structure of BAG family molecular chaperone regulator 4 (right; PDB ID 
4HWH), identified as a close match by DALI server (http://ekhidna.biocenter.helsinki.fi/dali_server/)  
(D) Crystal packing contacts in the talin R7R8/RIAM complex (PDB ID 4W8P). RIAM helix 
(magenta) bound to the R7R8 talin fragments (green) makes contacts with the symmetry-related 
talin R7 domain (red) that may induce the kink in the RIAM helix. A straight helix would clash with 
the symmetry-related R7. 
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Figure S2, related to Figures 4 and 5. Point mutations disrupt the interaction between talin 
R8 and DLC1 or paxillin.  
(A) Superposition of the HSQC spectra of 0.2 mM K1523E mutant of talin R7R8 free (blue) and in 
the presence of 0.8 mM DLC1(461-489) (red).  
(B) Superposition of the HSQC spectra of 0.2 mM talin R7R8 free (blue) and in the presence of 0.8 
mM D470K/E488K DLC1(461-489) mutant (red).   
(C) Superposition of the HSQC spectra of 0.2 mM K1544E mutant of talin R7R8 free (red) and in 
the presence of 0.8 mM of paxillin LD1 (blue).  
(D) GST-talin R1530E binds DLC1 less well than the K1544E mutant. Wild-type or mutant GST-
R8 talin fragment were co-transfected with GFP-DLC1 into 293T cells. Cell extracts were subjected 
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to pull-down assay with glutathione beads followed by immunoblotting with anti-GST and anti-
DLC1 on the same membrane (top). The transfected GFP-DLC1 in each sample is shown by the 
anti-DLC1 blot (bottom) as a loading control.  
(E) Superposition of the HSQC spectra of 0.2 mM of talin R7R8 free (blue), and in the presence of 
0.2 mM of RIAM TBS1 (red).  
(F) Superposition of the HSQC spectra of 0.2 mM of R1530E/K1544E mutant of talin R7R8 free 
(blue), and in the presence of 0.2 mM of RIAM TBS1 (red). 
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Figure S3, related to Figures 1 and 5. Dissociation constants for DLC1, RIAM and paxillin 
interactions with talin R8.  
(A) Examples of the chemical shifts changes in the 1H,15N-HSQC spectra of talin R8 on the 
addition of the peptide ligands used to determine Kd values. Symbols represent experimental 
chemical shift differences. Solid lines of the corresponding colours show the fitted curves. For each 
curve, chemical shift changes are normalised to the last value.   
(B) Superposition of the HSQC spectra for each of the cross-peaks used in the fitting in (A). 
Limited resonance broadening throughout the titration confirms fast exchange regime for the cross-
peaks used in the Kd measurements.  
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Figure S4, related to Figure 6. Expression of GST-talin R8 alone is insufficient to cause 
significant biological changes in A549 cells.  
(A)  Co-transfection of A549 cells with GFP-DLC1 and either GST, GST-R8 wt, or GST-R8 2E 
constructs. Six days after transfection, A549 cell extracts were analysed by anti-DLC1 (left) and 
anti-GST (right) immunoblotting (IB). Note – GST constructs were purified on glutathione beads 
prior to immunoblotting, and were expressed at similar levels. 
(B) Cell migration. Transfected cells were analysed using a transwell migration assay as 
described in methods. The lysates from migrated cells were quantitated (top), and representative 
microscopic images of the migrated cells are shown (bottom). As expected, GFP-DLC1 
suppressed cell migration whereas the the biological activity of the talin R8 wt and 2E mutant was 
similar to that of the GST negative control.  
(C) G418 colony growth. The transfected cells were cultured in G418 for 3 weeks, and the 
colonies were counted and quantitated (top). Representative stained colonies are shown (bottom). 
As expected, GFP-DLC1 suppressed colony formation whereas the biological activity of the talin 
R8 wt and 2E mutant was similar to that of the GST negative control.  
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(D) Growth in soft agar.  The transfected cells were grown 3 weeks in soft agar, and the colonies 
were counted and quantitated (top). Representative stained whole dishes are shown (bottom).  As 
expected, GFP-DLC1 suppressed growth in soft agar whereas the biological activity of the talin R8 
wt and 2E mutant was similar to that of the GST negative control.  
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Figure S5, related to figure 6. RIAM is expressed at low levels in A549 cells and does not 
form a detectable complex with GST-talin R8.  
(A) The expression of endogenous RIAM in cell lines. Cell extracts were subjected to 
immunoprecipitation followed by immunoblotting with anti-RIAM antibody.  
(B) A complex between GST-talin R8 and endogenous RIAM is undetectable in A549 cells. 
A549 cells were co-transfected with GFP-DLC1 and the GST constructs indicated. Cell extracts 
were subject to a glutathione bead pull down assay followed by immunoblotting with anti-GST 
and anti-RIAM antibodies on the same membrane (left).  No complex between GST-talin R8 and 
RIAM could be detected. Under the same conditions, wild-type GST-R8 pulled-down the co-
transfected GFP-DLC1; the immunoblot with anti-GST and anti-DLC1 on the same membrane is 
shown (right).  The amount of transfected GFP-DLC1 in each sample (loading control) is shown 
by the anti-DLC1 blot (bottom).  
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Figure S6, related to figure 5. Binding of GST-talin R8 to endogenous paxillin is 
undetectable in A549 and H358 cells.  
(A) The expression of endogenous paxillin in cell lines. Cell extracts were assayed by 
immunoblotting with anti-paxillin antibody.  
(B) A complex of GST-talin R8 with endogenous paxillin is undetectable in A549 (top) and 
H358 (bottom) cells. Cells were transfected with the GST constructs indicated, and cell extracts 
subjected to a glutathione bead pull down assay followed by immunoblotting with anti-GST and 
anti-paxillin antibodies on the same membrane.  
(C) Wild-type GST-talin R8 forms a complex with transfected paxillin in 293T cells. Extracts 
of 293 cells co-transfected with the GST constructs indicated and paxillin-DDK (OriGene) were 
subjected to pull-down assays with glutathione beads followed by immunoblotting with anti-GST 
and anti-DDK antibodies on the same membrane. While GST-talin R8 wt formed a complex with 
paxillin-DDK, the amount of paxillin complexed to the GST-talin R8 mutants was significantly 
reduced. The transfected paxillin-DDK in each sample is shown by the anti-DDK blot (bottom) as a 
loading control. 
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 Supplementary Methods 
Peptides and protein preparation – Recombinant wild-type mouse talin1 fragment R7R8 
(residues 1357-1653) was previously cloned into pET151/D-TOPO expression vector (Invitrogen), 
encoding an N-terminal hexa-histidine tag (Gingras et al., 2010). Site directed R7R8 mutants were 
produced by overlap extension PCR, and subsequent ligation-independent cloning into pOPINB 
vector (OPPF-UK); constructs were verified by sequencing. Both vectors include N-terminal hexa-
histidine tag followed by TEV protease cleavage site.  
Proteins were expressed and purified as described previously (Gingras et al., 2010). Briefly, protein 
was produced in BL21 STAR (DE3) cultured in LB or 2xM9 minimal medium containing 1 g/L of 15N-
labelled NH4Cl. Cells were grown at 37 
oC to an OD600 of 0.6, cooled to 18 
oC and induced using 0.5 
mM IPTG for 16 hours. Recombinant His-tagged protein was purified by nickel-affinity 
chromatography following standard protocol. The tag was removed by cleavage with TEV protease, 
followed by the reverse purification. Protein was further purified using anion exchange 
chromatography using a 5 ml Hi-Trap QFF column (GE Healthcare). 
Paxillin LD1 (1MDDLDALLADLESTTS16) and LD2 (141NLSELDRLLLELNAVQHNPP160) (Mus 
musculus) were synthesised at the proteomics facility at University of Nottingham; DLC1 TBS 
peptides (467PELDDILYHVKGMQRIVNQWSEK489 and 
461ENEDIFPELDDILYHVKGMQRIVNQWSEK489) (Homo sapiens) were synthesised by GL Biochem 
(Shanghai, China). Peptides were purified to >95% by reverse-phase chromatography and 
sequence analysed by mass spectrometry. 
X-ray crystallography – Diffraction data were collected at beamline i03 (Diamond light source) at a 
wavelength of 0.97Å. Intensities were integrated and scaled using iMOSFILM and SCALA (Evans, 
2006), with 5% of reflections randomly isolated from refinement. The DLC1-R7R8 complex was 
solved using molecular replacement using the structure of the free R7 domain as a template (PDB 
ID 2X0C) (Gingras et al., 2010). Molecular replacement was performed using PHASER (McCoy et 
al., 2007)  and modelling was performed using COOT 0.8.1 (Emsley and Cowtan, 2004).  
Initial electron density maps showed that the position of the R8 domain had changed, and once 
repositioned, and the R7R8 domain modelled, electron density for the DLC1 peptide was clearly 
visible, as demonstrated in the simulated annealing composite omit map (Supplementary Figure 
S1A). Electron density was visible for the entire helix and allowed unambiguous assignment of 
electron density. Refinement was performed using isotropic B-factors, and at the final stage of 
refinement employed the use of TLS parameters determined by the TLS motion determination 
server (Painter and Merritt, 2006), TLS groups included residues 1354-1466 and 1467-1659 of 
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R7R8 and the entire DLC1 peptide, 467-469. Refinement and validation were performed using 
PHENIX 1.10 (Adams et al., 2010). Data reduction and refinement statistics are shown in Table 1. 
NMR Spectroscopy - Spectra were processed with TopSpin (Bruker) and analysed using CCPN 
Analysis (Vranken et al., 2005). Resonance assignment was carried out as described previously 
(Goult et al., 2008). The changes in chemical shift of 15N-talin R8 domain were calculated from 
1H,15N-HSQC spectra as Δδ=√(ΔδH2+(ΔδN*0.15)2). The cross-peaks corresponding to the 
bound state were assigned by following chemical shift changes throughout the R8 titration with the 
increasing amount of peptides. 
Dissociation constants were evaluated from the 1H,15N-HSQC chemical shift changes in the titration 
experiments conducted using 0.1 mM 15N-talin R8 domain. Peptides were added from 5-10 mM 
stock solutions to generate titration points at 0.1, 0.2, 0.5, 0.75, 1, 2, 4 and 8 peptide:protein ratios. 
Concentrations of the DLC1 and RIAM peptides were determined from UV absorbance at 280 nm. 
Concentrations of the paxillin peptide that lacks UV-active aromatic residues was determined by 
NMR from the comparison of the integral intensities of the well-separated signals of the methyl 
groups of the paxillin and RIAM peptides following the Eretic2 procedure of TopSpin (Bruker). 
Concentration of the R8 domain that lacks UV-active aromatic residues was estimated from the 
comparison with the spectra of the R3 domain that has similar molecular weight and shape using 
the calibration procedure described in (Wider and Dreier, 2006).  Dissociation constants were 
determined by fitting the chemical shift changes to the equation: 
∆(𝐻,𝑁) = ∆(𝐻,𝑁)0
[𝑃] + [𝐿] + 𝐾𝑑 − √([𝑃] + [𝐿] + 𝐾𝑑)2 − 4[𝑃][𝐿]
2[𝑃]
 
where ∆(𝐻,𝑁)0 is the weighted chemical shift difference at saturation, [P] and [L] are protein and 
ligand concentrations, respectively. Data were fitted independently for the well-resolved peaks and 
the average Kd was calculated from 3 different peaks with the lowest standard deviations of the fits. 
For DLC1 and RIAM only signals in fast exchange regime were selected for the analysis. 
DNA Constructs and transfection - The plasmids expressing GFP-DLC1 and GST fusion proteins 
with talin rod fragments encoding talin amino acids 1288-1646 and 1453-1580 (R8) were described 
previously (Li et al., 2011). The plasmid encoding 1352-1580 (R7R8) was engineered by PCR, and 
subcloned into a eukaryotic expression vector, PEBG (Anborgh et al., 1999), using BamHI and NotI 
sites. The point mutations, K1530E/K1544E, in R8 were made individually and in combination by 
site-directed mutagenesis using a mutagenesis kit (Agilent). Human Paxillin-DDK (PXN) plasmid 
was from OriGene. 
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HEK 293T cells were transfected by lipofectamine 2000 and DLC1-null lung adenocarcinoma cell 
lines A549 and H358 cells were transfected by lipofectamine 3000 according to manufacturer 
instructions (Invitrogen). Cells were co-transfected with plasmids expressing GFP-DLC1 or Paxillin-
DDK and GST, GST-talin fragments, or vector at a ratio of 1:2.5.  Cells were incubated at 37 oC in a 
humidified 5% CO2 atmosphere. 
 
In vivo pull-down assay, co-immunoprecipitation, and immunoblotting - As described 
previously (Qian et al., 2009), two days after transfection, cell extracts were collected using golden 
lysis buffer (GLB: 20 mM Tris pH 7.9, 137 mM NaCl, 10% glycerol, 1% Triton, 5 mM EDTA, 1 mM 
EGTA, 1 mM Na3VO4, 10 mM NaF, 1 mM sodium pyrophosphate, 0.5 mM β-glycerophosphate, 
and protease inhibitor cocktail tablet (Roche)). The cleared supernatants were collected, and the 
amount of protein estimated by BCA kit (Pierce). Equal amounts of protein from cell extracts were 
used for pull-down assays by adding 25 µl of glutathione Sepharose-4B slurry (GE Healthcare) and 
rotating  for 3 h at 4 °C. The pellets were washed once with GLB, once with high salt HNTG (20 mM 
Hepes, 500 mM NaCl, 0.1% Triton-X, 10% glycerol), and twice with low salt HNTG (20 mM Hepes, 
150 mM NaCl, 0.1% Triton, 10% glycerol), and incubated with Laemmli sample buffer. After 
separating the protein samples in SDS-PAGE, the transferred membranes were used for detecting 
the pull-down proteins by antibody against GST (Santa Cruz), DLC1 (BD Biosciences) and RIAM 
(Boster Biological Technology Co.) or DDK (OriGene). For co-immunoprecipitation experiments of 
GFP-DLC1 with endogenous talin, the saved supernatants from each pull-down sample were 
incubated with anti-talin antibody (Sigma Aldrich). 25 μl of Protein A/G slurry (Pierce) were added to 
each immune reaction and rotated overnight at 4 °C. The immuno-pellets were washed four times 
as described for the pull-down assay. Separation of protein samples by SDS-PAGE was followed by 
immunoblotting using anti-DLC1 or anti-talin antibody. For each blot, horseradish peroxidase-
conjugated anti-rabbit or anti-mouse immunoglobulin G (GE Healthcare) was used for the second 
reaction at 1:10,000 dilution. Immunocomplexes were visualised by enhanced chemiluminescence 
(ECL), using an ECL kit (GE Healthcare). 
 
G418 colony growth, soft agar growth and cell migration assays - As described previously 
(Qian et al., 2009), transfected A549 cells were counted, and equal numbers of cells were seeded in 
triplicate 60 mm dishes (5 x 105 per well) overnight, and cultured with RPMI-1640 media containing 
0.9 mg/ml G418 (Invitrogen) for 3 weeks.  The G418 resistant colonies were stained by 0.5% crystal 
violet and counted for graph using Prism. For soft agar colony assays, 1 × 105 cells were mixed with 
complete medium containing 0.4% agar (Difco) and grown in 60 mm dishes over a thin layer of 
0.6% basal agar. Cells were grown for 2-3 weeks, and colonies were photographed microscopically 
and quantified by a colony counter. Transwell cell migration assays were performed with 6.5 mm 
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diameter Falcon cell culture inserts (8 μm pore size; Thermo Fisher) precoated with 0.01% gelatin, 
in 24 well cell culture plates. Cells were trypsinized and resuspended in serum-free media, then 
transferred to the upper chamber (5 × 104 cells in 350 μl); 800 μl of media containing 10% FBS 
were added to the lower chamber. After incubation for 24 h, cells remaining on the upper surface of 
the filter were removed with a cotton swab; cells that had migrated to the lower surface were fixed, 
stained with 0.5% crystal violet for 10 min, destained, visualised microscopically, and photographed. 
The migrated cells were then solubilised overnight with 1% Triton-X-100. The collected lysates were 
quantified colorometrically in a spectrophotometer using OD590nm. 
 
Ratio imaging - Talin1 and talin2 knock out cells were generated and cultured as described in 
(Atherton et al., 2015). Transient transfections were performed using Lipofectamine and Plus 
reagents (Life Technologies) as per the manufacturer’s instructions. 
Mouse anti-paxillin antibody (clone 349/Paxillin) (BD Transduction Laboratories, Europe) and Goat-
anti DLC-1 (sc-32931, Santa Cruz Biotechnology) were diluted (1:500) in 1% Bovine Serum 
Albumin (BSA) (cat: V9131, Sigma, UK). Dylight 594-conjugated AffiniPure Donkey Anti-Mouse IgG 
(cat: 715-585-150, Jackson ImmunoResearch, USA) and Dylight 594-conjugated AffiniPure Donkey 
Anti-Goat IgG (cat: 705-586-147, Jackson ImmunoResearch, USA) were used as a secondary 
antibodies, diluted in 1% BSA (1:500).  
Cells transfected with GFP-talin proteins were incubated overnight on glass bottom dishes 
(MatTek), fixed with 4% paraformaldehyde and permeabilised with 0.5% Triton X-100 (Sigma). 
Samples were incubated with the primary antibody for 60 min, and then washed thrice with PBS. 
Secondary antibody staining followed the same procedure. Fixed samples were imaged using a 
Delta Vision RT microscope (Applied Precision) equipped with a 60 × /1.42 Plan Apo oil immersion 
objective (Zeiss). Images were acquired with a CoolSnap HQ camera (Photometrics). 
Image analysis was carried out using Fiji ImageJ (version 1.48d) software. All cells analysed had 
low to intermediate levels of talin. Expression levels were determined by fluorescence intensities 
measured across a large number of cells exposed to the same amount of fluorescent light. For ratio 
quantification, GFP-talin and DLC1 or paxillin immunofluorescence images were background 
subtracted, a region of interest was selected around an individual peripheral adhesion (5 per cell) 
and the integrated density measured for both channels. Dividing the values from paxillin or DLC1 by 
talin then produced a ratio. 
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